By Sherri Oslick --
About
Court Report: Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.
Shire, LLC v. Teva Pharmaceutical Industries Ltd. et. al.
1:07-cv-03526; filed May 2, 2007 in the Southern District of New York
Infringement of U.S. Patent Nos. 5,326,570 ("Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine," issued July 5, 1994) and 5,912,013 (same title, issued June 15, 1999) following a paragraph IV certification as part of Teva's filing of an ANDA to manufacture a generic version of Shire's Carbatrol® (carbamazepine, used to treat seizure disorders or trigeminal neuralgia). View the complaint here.
Janssen Pharmaceutica N.V. et. al. v. Sandoz, Inc.
3:07-cv-02058; filed May 2, 2007 in the District Court of New Jersey
Infringement of U.S. Patent No. 4,663,318 ("Method of Treating Alzheimer's Disease," issued May 5, 1987) following a paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Janssen's Razadyne ER® (formerly Reminyl®) (galantamine hydrobromide, used to treat mild to moderate dementia of the Alzheimer's type). View the complaint here.
Merck & Co. Inc. v. Ranbaxy Inc. et. al.
1:07-cv-00229; filed April 30, 2007 in the District Court of Delaware
Infringement of U.S. Patent No. 5,147,868 ("Thienamycin Renal Peptidase Inhibitors," issued September 15, 1992) based on Ranbaxy's filing of an ANDA to manufacture a generic version of Merck's Primaxin® I.V. (imipenem and cilastatin for injection, used to treat bacterial infection). View the complaint here.
Anticancer Inc. v. Perry Scientific Inc. et. al.
3:07-cv-00778; filed April 27, 2007 in the Southern District of California
Infringement of U.S. Patent Nos. 5,491,284 ("Nude Mouse Model for Neoplastic Disease," issued February 13, 1996) and RE39,337 (same title, issued October 10, 2006), directed to murine models for neoplastic disease. View the complaint here.
Monsanto Co. et. al. v. Randy Foster
4:07-cv-00833; filed April 25, 2007 in the Eastern District of Missouri
Infringement of U.S. Patent Nos. 5,352,605 ("Chimeric Genes for Transforming Plant Cells Using Viral Promoters," issued October 4, 1994) and RE39,247 ("Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate Synthases," issued August 22, 2006) based on defendants' use of soybean seed produced from earlier planted Roundup Ready® soybean seed. View the complaint here.
Comments